Rearrangements of chromosome band 3q21 in myeloid leukemia.

Authors:

Leuk Lymphoma 2002 Jan;43(1):59-65

Institut für Medizinische Biologie der Universitaet Wien, Vienna, Austria.

Chromosome rearrangements affecting band 3q21, namely, the inv(3)(q21q26), the t(3;3)(q21;q26), and the t(1;3)(p36;q21), are associated with a particularly poor prognosis in myeloid leukemia or myelodysplasia. Originally, inv(3) and t(3;3) breakpoints have been reported to cluster in a region (breakpoint cluster region, BCR) of approximately 30 kb, which is located centromeric and downstream of the ribophorin I (RPN-I) gene. More recently, we established a PAC contig that includes the 3q21 BCR, and used these PAC clones to map breakpoints in patient samples by both metaphase and interphase fluorescence in situ hybridization (FISH) analysis. A significant proportion of inv(3) and t(3;3) breakpoints was located at sometimes considerable distances centromeric of the originally described BCR, in a region recently also implicated in t(1;3) rearrangements. These breakpoints may thus define a second, centromeric BCR (BCR-C), or extend the original 3q21 BCR to a size of approximately 100 kb. Activation of the EVI-1 gene in 3q26 by regulatory sequences of the housekeeping gene RPN-I has been suggested as a leukemogenic mechanism in patients with inv(3) and t(3;3). However, despite a number of characteristics that make EVI-1 an attractive candidate oncogene, its biological properties fail to fully explain the phenotype of leukemias carrying 3q rearrangements. Several additional candidate genes have been identified in or near the 3q21 breakpoint region, but their possible contribution to the characteristics of leukemias with 3q21 rearrangements remains to be explored.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190210196DOI Listing
January 2002
1 Read

Publication Analysis

Top Keywords

inv3 t33
12
myeloid leukemia
8
3q21 bcr
8
band 3q21
8
t33 breakpoints
8
cluster region
8
3q21
6
bcr
5
rearrangements
5
extend original
4
original 3q21
4
bcr-c extend
4
bcr bcr-c
4
second centromeric
4
centromeric bcr
4
bcr size
4
regulatory sequences
4
define second
4
activation evi-1
4
100 activation
4

References

(Supplied by CrossRef)

Pintado T. et al.
Cancer 1985

Jenkins R. et al.
Cancer Genet. Cytogenet. 1989

Grigg A. et al.
Br. J. Haematol. 1993

Fonatsch C. et al.
Leukemia 1994

Horsman D. et al.
Leuk. Lymph. 1995

Secker Walker L. et al.
Br. J. Haematol. 1995

Shi G. et al.
Cancer Genet. Cytogenet. 1997

Sancho J. et al.
Medicina Clinica 1999

Testoni N. et al.
Haematologica 1999

Reiter E. et al.
Ann. Hematol. 2000

Bernstein R. et al.
Blood 1982

Similar Publications